Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Tough

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
ACS Chemical Biology|September 12, 2018
Modulating PCAF/GCN5 Immune Cell Function through a PROTAC ApproachZuni I Bassi, Martin C Fillmore, Afjal H Miah, et al.
Blood|December 17, 2013
Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762Aristeidis Chaidos, Valentina Caputo, Katerina Gouvedenou, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Science (New York, N.Y.)|March 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammationOmer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
BMC Biology|August 19, 2022
Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140Mohammed Ghiboub, Jan Koster, Peter D Craggs, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
ACS Chemical Biology|September 12, 2018
Modulating PCAF/GCN5 Immune Cell Function through a PROTAC ApproachZuni I Bassi, Martin C Fillmore, Afjal H Miah, et al.
Blood|December 17, 2013
Potent antimyeloma activity of the novel bromodomain inhibitors I-BET151 and I-BET762Aristeidis Chaidos, Valentina Caputo, Katerina Gouvedenou, et al.
Journal of Medicinal Chemistry|June 22, 2026
Discovery of an Orally Available Potent ER Aminopeptidase 1 (ERAP1) Inhibitor That Enhances Antitumor Responses and Limits Inflammatory Autoimmunity <i>In Vivo</i>Christopher P Tinworth, Justyna Wojno-Picon, Michael Adam, et al.
Science (New York, N.Y.)|March 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammationOmer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
BMC Biology|August 19, 2022
Modulation of macrophage inflammatory function through selective inhibition of the epigenetic reader protein SP140Mohammed Ghiboub, Jan Koster, Peter D Craggs, et al.
Pageof 9